Demo

537 Articles Matching "approves"

State Highlights: New York Taking Steps Toward Legalizing Marijuana; Massachusetts House Approves Plan To Help Community Hospitals

Jun 21, 2018 , Kaiser Health News
Media outlets report on news from New York, Massachusetts, Maryland, Texas, California, Montana, Kansas and...
Read more

Canada Senate approves recreational use of marijuana

Jun 20, 2018 , Reuters
TORONTO (Reuters) - Canada's upper house of parliament on Tuesday approved a revised bill to legalize recreational marijuana, setting the stage for the country to become the first Group of Seven nation to legalize cannabis....
Read more

FDA approves wearable device for opioid withdrawal symptom treatment device

Jun 16, 2018 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal. The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European...
Read more

FDA approves Alembic’s generic Wellbutrin

Jun 14, 2018 , Drug Store News - Retail
The product’s market size for the 12 months ended December 2017 was $37 million, according to IQVIA data. Read More...
Read more

FDA approves expanded Rituxan indication

Jun 14, 2018 , Drug Store News - Retail
With this approval — which saw the drug given Priority Review, Breakthrough Therapy Designation and Orphan Drug Designation by the FDA — Rituxan becomes the first biologic therapy for the disease. Read More...
Read more
Demo

Perspectives: FDA Needs To Demand More From The Drugs It Approves

Jun 14, 2018 , Kaiser Health News
Read recent commentaries about drug-cost...
Read more

San Francisco approves ban on menthol cigarettes and flavored e-cigarette liquids

Jun 07, 2018 , CNBC Health
The results could spark momentum for other cities to pursue similar...
Read more

FDA approves Mylan drug as first biosimilar to Amgen's Neulasta

Jun 05, 2018 , Reuters
(Reuters) - Mylan NV on Monday beat a clutch of drugmakers racing to get a biosimilar to Amgen Inc's blockbuster drug, Neulasta, to market, with U.S. health regulators approving its version of the infection-fighting treatment....
Read more

FDA Approves 1st Artificial Iris

Jun 01, 2018 , WebMD
The surgically implanted device can be used on adults and children whose iris is missing, has been damaged by a congenital condition called aniridia, or has been injured, the agency said in a news...
Read more

FDA approves BioMarin rare metabolic disorder drug, shares rise

May 25, 2018 , Reuters
(Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours....
Read more

FDA approves Glenmark’s Welchol generic

May 25, 2018 , Drug Store News - Retail
Glenmark said that it had already started supplying the product in the United States. Read More...
Read more
Banner Health Children

FDA Approves First Non-Opioid for Withdrawal

May 20, 2018 , MedicineNet
Title: FDA Approves First Non-Opioid for WithdrawalCategory: Health NewsCreated: 5/18/2018 12:00:00 AMLast Editorial Review: 5/18/2018 12:00:00...
Read more

FDA Approves First Drug Aimed at Preventing Migraines

May 20, 2018 , MedicineNet
Title: FDA Approves First Drug Aimed at Preventing MigrainesCategory: Health NewsCreated: 5/18/2018 12:00:00 AMLast Editorial Review: 5/18/2018 12:00:00...
Read more

FDA Approves First Non-Opioid for Withdrawal

May 20, 2018 , RxList
The FDA approved the first non-opioid drug, lofexidine hydrochloride (Lucemyra), to help treat symptoms of opioid withdrawal in...
Read more

FDA Approves First Non-Opioid for Withdrawal

May 19, 2018 , eMedicine Health
FDA Approves First Non-Opioid for...
Read more

FDA approves first non-opioid treatment for opioid withdrawal

May 18, 2018 , Drug Store News - Clinical Retail
The U.S. Food and Drug Administration has approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for management of opioid withdrawal symptoms in adults. Read More...
Read more

FDA approves new Amgen drug for prevention of migraines

May 18, 2018 , CNBC Health
Amgen won FDA approval on Thursday for the first drug to prevent migraine headaches in...
Read more

U.S. FDA approves Amgen drug for prevention of migraines

May 18, 2018 , Reuters
(Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults....
Read more

FDA Approves First Non-Opioid for Withdrawal

May 18, 2018 , WebMD
The FDA found the drug to be safe and effective in easing symptoms such as diarrhea, nausea, vomiting, anxiety, and an overall feeling of sickness that often keep patients from withdrawing from...
Read more

FDA Approves Amgen's Migraine Drug

May 18, 2018 , Forbes
The drug’s list price is $6,900 per year, or $575 per monthly injected dose, lower than many market-watchers...
Read more